| Bioactivity | Cavα2δ1&NET-IN-3 (example 216) is an inhibitor of the subunit α2δ of voltage-gated calcium channels (VGCC) and noradrenaline transporter (NET). Cavα2δ1&NET-IN-3 has Kis of 100-500 nM for human α2δ-1 subunit of Cav2.2 calcium channel and NET, respectively[1]. |
| Name | Cavα2δ1&NET-IN-3 |
| CAS | 2143584-82-9 |
| Formula | C24H30N6O2S |
| Molar Mass | 466.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Félix CUEVAS-CORDOBÉS, et al. Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions. WO2017191304A1. |
Cavα2δ1&NET-IN-3
CAS: 2143584-82-9 F: C24H30N6O2S W: 466.60
Cavα2δ1&NET-IN-3 (example 216) is an inhibitor of the subunit α2δ of voltage-gated calcium channels (VGCC) and norad
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.